Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Rite Aid Corporation Common Stock
(NY:
RAD
)
N/A
UNCHANGED
Last Price
Updated: 7:00 PM EDT, Oct 13, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Rite Aid Corporation Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
CVS Health Corporation Is Coiled And Ready To Spring Higher
February 09, 2023
The price action in CVS Health has been coiling up over the last 15 months and it looks ready to spring higher.
Via
Talk Markets
CVS Health Corporation Is Coiled And Ready To Spring Higher
February 08, 2023
CVS Health strategy to become a diversified healthcare operator is paying off and the analysts clearly approve. Earnings shine and guidance is good, too.
Via
MarketBeat
Is Amazon the Future of Healthcare?
January 25, 2023
The e-commerce titan announced the RxPass subscription for Prime members. What companies will this service disrupt, and can Amazon stock benefit?
Via
The Motley Fool
CVS Health is Growing into an Integrated Healthcare Organization
January 23, 2023
Pharmacy, insurance, and healthcare services provider CVS Health Corporation (NYSE: CVS) shares are trading near 52-week lows despite the recent rally in the
Via
MarketBeat
Exposures
COVID-19
Stocks That Hit 52-Week Lows On Friday
January 20, 2023
Friday saw 23 companies set new 52-week lows.
Via
Benzinga
Rite Aid (RAD) Q3 2023 Earnings Call Transcript
December 21, 2022
RAD earnings call for the period ending September 30, 2022.
Via
The Motley Fool
Why Rite Aid's Shares Dropped 17.3% on Wednesday
December 21, 2022
Earnings left a lot to be desired.
Via
The Motley Fool
Google Layoffs 12K Employees, Netflix's Q4 Earnings And CEO Steps Down, FDA Rejects Eli Lilly's Alzheimer's Candidate: Top Stories Friday, Jan. 20
January 20, 2023
Here's a round-up of stories from around the globe and from various media outlets. Benzinga
Via
Benzinga
Rite Aid Starts Selling Abortion Medication From Few Pharmacies: Report
January 20, 2023
Rite Aid Corp (NYSE: RAD) plans to dispense abortion pill mifepristone in a limited number of its pharmacies and will serve customers in person or through mail delivery.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
January 19, 2023
On Thursday, 29 stocks made new 52-week lows.
Via
Benzinga
Is Walgreens Boots Alliance Earnings Miss Good For Investors?
January 17, 2023
Integrated healthcare and pharmacy retailer Walgreens Boots Alliance Inc. (NYSE: WBA) stock recovered some sell-off losses from its fiscal Q1 2023 earnings
Via
MarketBeat
Topics
Earnings
Lawsuit
Exposures
COVID-19
Financial
Legal
Rite Aid Beats On Q3; Widens FY23 Loss Forecast Citing Headwinds
December 21, 2022
Via
Benzinga
Rite Aid Earnings Preview
December 20, 2022
Via
Benzinga
5 Retail Stocks to Put on Your 2023 Death Watch
January 13, 2023
Survival for any of these retail stocks to sell would mean big profits for investors who buy now, but that's not the way to bet.
Via
InvestorPlace
Jim Cramer Says Forget AT&T, This 'Class Of The Field' Communications Stock Is Better
January 10, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said ADMA Biologics, Inc. (NASDAQ: ADMA) is a "great spec, but it is losing money hand over fist. I think it’s very binary.
Via
Benzinga
Rite Aid Corporation Names Elizabeth “Busy” Burr Interim Chief Executive Officer
January 09, 2023
From
Rite Aid Corporation
Via
Business Wire
Over $400M Robinhood Stock Linked To Sam Bankman-Fried, Dell Eyes Reducing Dependence On China, Walgreens Swings To Quarterly Loss: Top Stories Today
January 05, 2023
Benzinga
Via
Benzinga
Walgreens Boots Alliance Might Be First Pharmacy To Dispense Abortion Pills, Others To Follow
January 05, 2023
Via
Benzinga
Novartis Settles Antitrust Cases Related To Generic Entry For Hypertension Drug
December 29, 2022
Novartis AG (NYSE: NVS) will pay $245 million to end antitrust litigation accusing the company of trying to delay the U.S. launch of generic versions of its Exforge, which treats hypertension to lower...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 22, 2022
Thursday's session saw 329 companies set new 52-week lows.
Via
Benzinga
Why Walgreens Boots Alliance Stock Caught a Cold Today
December 21, 2022
The pharmacy sector in general didn't look too attractive on Hump Day.
Via
The Motley Fool
Why Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday's Mid-Day Session
December 21, 2022
Gainers Sintx Technologies, Inc. (NASDAQ: SINT) shares climbed 81.4% to $13.55 after the company was awarded Phase I contract for $150,000 from the Missile Defense Agency for electrochemical...
Via
Benzinga
Institutions Put Bottom In Rite Aid Shares
December 21, 2022
Rite Aid Corporation is on the cusp of bottoming and may already have its lowest price, if the institutions start buying again the stock could double.
Via
MarketBeat
Exposures
COVID-19
BlackBerry, Calavo Growers And Some Other Big Stocks Moving Lower On Wednesday
December 21, 2022
U.S. stocks traded higher, with the Dow Jones gaining over 500 points on Wednesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Dow Surges 300 Points; US Current Account Deficit Narrows In Third Quarter
December 21, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining around 300 points on Wednesday.
Via
Benzinga
Rite Aid Corporation Reports Fiscal 2023 Third Quarter Results
December 21, 2022
From
Rite Aid Corporation
Via
Business Wire
Earnings Scheduled For December 21, 2022
December 21, 2022
Companies Reporting Before The Bell • Rite Aid (NYSE:RAD) is expected to report quarterly loss at $0.31 per share on revenue of $5.94 billion.
Via
Benzinga
RAD FINAL DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Rite Aid Corporation Investors to Secure Counsel Before Important December 19 Deadline in Securities Class Action - RAD
December 17, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
RITE AID DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Rite Aid Corporation and Encourages Investors to Contact the Firm
December 16, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
Shareholder Alert: Lowey Dannenberg Reminds Rite Aid Corporation (NYSE: RAD) Investors of Securities Class Action Lawsuit and Upcoming Lead Plaintiff Deadline
December 16, 2022
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.